Published in Assay Drug Dev Technol on October 01, 2004
A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards. J Cardiovasc Transl Res (2012) 1.00
Current status of drug screening and disease modelling in human pluripotent stem cells. Bioessays (2012) 0.98
The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening. Br J Pharmacol (2013) 0.94
Microfabricated electrochemical cell-based biosensors for analysis of living cells in vitro. Biosensors (Basel) (2012) 0.94
Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform. Biochim Biophys Acta (2015) 0.92
Using physiologically based models for clinical translation: predictive modelling, data interpretation or something in-between? J Physiol (2016) 0.83
Screening out irrelevant cell-based models of disease. Nat Rev Drug Discov (2016) 0.83
Drug discovery models and toxicity testing using embryonic and induced pluripotent stem-cell-derived cardiac and neuronal cells. Stem Cells Int (2012) 0.82
On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip. Sci Rep (2014) 0.81
Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes. Stem Cells Dev (2016) 0.80
High yield purification of full-length functional hERG K+ channels produced in Saccharomyces cerevisiae. Microb Cell Fact (2015) 0.75
Scalable Electrophysiological Investigation of iPS Cell-Derived Cardiomyocytes Obtained by a Lentiviral Purification Strategy. J Clin Med (2015) 0.75
Micro-electrode arrays in cardiac safety pharmacology: a novel tool to study QT interval prolongation. Drug Saf (2004) 1.09
G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice. Oligonucleotides (2006) 0.99
New cell models and assays in cardiac safety profiling. Expert Opin Drug Metab Toxicol (2007) 0.83
Rapid functional evaluation of beta-cells by extracellular recording of membrane potential oscillations with microelectrode arrays. Pflugers Arch (2011) 0.81
Automated higher-throughput compound screening on ion channel targets based on the Xenopus laevis oocyte expression system. Assay Drug Dev Technol (2004) 0.78